Epicardial Adipose Tissue, Adiponectin and Leptin: A Potential Source of Cardiovascular Risk in Chronic Kidney Disease

Liabeuf et al., “Serum indoxyl sul- fate is associated with vascular disease and mortality in chronic kidney disease patients,” Clinical Journal of the American Society of

Efficacy and safety of atorvastatin in the prevention of cardiovascular end points in subjects with type 2 diabetes: the Atorvastatin Study for Prevention of Coronary Heart

Several systems, molecules and responses involved in the pathogenesis of the pathological fibrosis of chronic kidney disease (CKD) will be discussed in this review, putting

Kopple, “Association of dietary phosphorus intake and phosphorus to protein ratio with mortality in hemodialysis patients,” Clinical Journal of the American Society of Nephrology,

The patients with ADPKD included in the study had worse renal function (worse mean estimated by glomerular filtration rate [eGFR], more in patients with CKD stage 4) and

Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy (CREDENCE), Dapagliflozin on Renal Outcomes and Cardiovascular Mortality in Patients with Chronic Kidney

A Study on the Relationship between Serum Beta 2-Microglobulin Levels, Underlying Chronic Kidney Disease, and Peripheral Arterial Disease in High-Vascular-Risk

NSAIDs increase the risk of cardiovascular disease in the general population, and although there is little direct evidence for elevated cardiovascular risk with NSAIDs in people